Table III.
Antifungal activity of MVO, F1 and F2F1: MVO in ointment base; F2: Microencapsulated MVO in ointment base; values are mean ± SE
| Parameters | Formulations | ||||
|---|---|---|---|---|---|
| MVO | Ointment base | F1 | F2 | ||
| Zone of growth inhibition in mm against different strains of Candida | Candida albicans (ATCC 14053) | 12.00 ± 1.16 | 0 | 12.67 ± 2.66 | 18.67 ± 0.88 |
| Candida albicans (Clinical isolates) | 08.67 ± 1.76 | 0 | 10.00 ± 0.58 | 14.67 ± 0.33 | |
| Candida kefyr (ATCC 204093) | 10.67 ± 0.67 | 0 | 11.33 ± 1.33 | 14.33 ± 0.33 | |
| Candida tropicalis (ATCC 201380) | 10.33 ± 1.20 | 0 | 10.67 ± 0.88 | 13.33 ± 1.76 | |